Iridex Corp. Company Profile (NASDAQ:IRIX)

About Iridex Corp.

Iridex Corp. logo

IRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company operates through ophthalmology segment. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes, and are used in the treatment of serious eye diseases, including the over three causes of irreversible blindness, such as diabetic retinopathy, glaucoma and age-related macular degeneration (AMD). In addition, the Company's ophthalmology products are often used in vitrectomy procedures (used to treat proliferative diabetic retinopathy, macular holes, retinal tears and detachments), which are generally performed in the operating room and require a consumable single use intraocular laser probe (EndoProbe) to deliver light to the back of the eye together with other instrumentation.

Industry, Sector and Symbol:

Sector: Computer and Technology
Industry: Medical Appliances & Equipment
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: IRIX
CUSIP:

Key Metrics:

Previous Close: $14.73
50 Day Moving Average: $14.78
200 Day Moving Average: $13.38
52-Week Range: $6.57 - $16.64
Trailing P/E Ratio: 226.62
P/E Growth: -16.80
Market Cap: $149.04M
Outstanding Shares: 10,118,000
Beta: 0.77

Profitability:

Net Margins: 1.43%
Return on Equity: 1.93%
Return on Assets: 1.55%

Debt:

Current Ratio: 3.77%
Quick Ratio: 2.37%

Additional Links:

Companies Related to Iridex Corp.:

Consensus Ratings for Iridex Corp. (NASDAQ:IRIX) (?)

Ratings Breakdown:	1 Buy Rating
Consensus Rating:	Buy (Score: 3.00)
Consensus Price Target:	$11.50 (21.93% downside)

Analysts' Ratings History for Iridex Corp. (NASDAQ:IRIX)

Show:

Date	Firm	Action	Rating	Price Target	Details
1/26/2016	Singular Research	Initiated Coverage	Buy	$11.50

(Data available from 9/25/2014 forward)

Earnings History for Iridex Corp. (NASDAQ:IRIX)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
11/3/2016
8/4/2016	Q216	$0.01	($0.03)	$11.90 million	$11.90 million	View	Listen
5/5/2016	Q116	$0.04	$0.01	$11.88 million	$11.90 million	View	Listen
3/3/2016	Q415	$0.04	$0.04	$11.80 million	$12.10 million	View	Listen
11/5/2015	Q315		$0.04	$10.10 million	$9.80 million	View	Listen
8/6/2015	Q215		($0.07)	$10.60 million	$9.00 million	View	Listen
5/7/2015	Q115		$0.02	$10.30 million	$10.80 million	View	Listen
3/5/2015	Q414		$0.97	$10.60 million	$11.80 million	View	Listen
5/1/2014	Q1	$0.06	$0.05	$8.90 million	$10.30 million	View	Listen
2/27/2014	Q4	$0.04	$0.04			View	Listen

(Data available from 1/1/2011 forward)

Earnings Estimates for Iridex Corp. (NASDAQ:IRIX)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Iridex Corp. (NASDAQ:IRIX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Iridex Corp. (NASDAQ:IRIX)

Insider Ownership Percentage: 26.40%
Institutional Ownership Percentage: 42.94%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/12/2016	Romeo R Dizon	Insider	Sell	125	$15.00	$1,875.00
9/7/2016	Ruediger Naumann-Etienne	Director	Sell	9,513	$14.75	$140,316.75
9/2/2016	Ruediger Naumann-Etienne	Director	Sell	2,513	$14.73	$37,016.49
8/23/2016	Romeo R Dizon	Insider	Sell	875	$14.52	$12,705.00
8/19/2016	Romeo R Dizon	Insider	Sell	7,896	$13.52	$106,753.92
8/16/2016	George R Marcellino	Director	Sell	2,513	$13.57	$34,101.41
8/16/2016	Romeo R Dizon	Insider	Sell	839	$13.70	$11,494.30
6/6/2016	Ronald Steckel	VP	Sell	625	$13.52	$8,450.00
5/17/2016	Ronald Steckel	VP	Sell	4,583	$12.81	$58,708.23
3/8/2016	Ronald Steckel	VP	Sell	12,000	$10.45	$125,400.00
11/19/2015	William M Moore	CEO	Buy	10,000	$9.83	$98,300.00
9/25/2015	Associates & Paragon A Paragon	Major Shareholder	Buy	52,042	$7.05	$366,896.10
9/10/2015	Associates & Paragon A Paragon	Major Shareholder	Buy	11,866	$6.95	$82,468.70
9/4/2015	Associates & Paragon A Paragon	Major Shareholder	Buy	10,304	$6.81	$70,170.24
9/2/2015	Ronald Steckel	VP	Sell	1,875	$6.80	$12,750.00
8/21/2015	Associates & Paragon A Paragon	Major Shareholder	Buy	20,651	$7.16	$147,861.16
8/19/2015	James H. Mackaness	CFO	Sell	2,373	$7.15	$16,966.95
8/19/2015	Ronald Steckel	VP	Sell	1,751	$7.14	$12,502.14
8/18/2015	James H. Mackaness	CFO	Sell	2,627	$7.10	$18,651.70
8/17/2015	James H. Mackaness	CFO	Sell	2,235	$7.05	$15,756.75
8/14/2015	James H Mackaness	CFO	Sell	7,765	$6.99	$54,277.35
8/14/2015	Ronald Steckel	VP	Sell	1,458	$7.00	$10,206.00
7/24/2015	Associates & Paragon A Paragon	Major Shareholder	Buy	40,403	$7.01	$283,225.03
6/17/2015	Ronald Steckel	VP	Sell	1,666	$8.77	$14,610.82
5/20/2015	James H Mackaness	CFO	Sell	2,000	$9.80	$19,600.00
5/18/2015	Ronald Steckel	VP	Sell	1,667	$9.33	$15,553.11
4/20/2015	Ronald Steckel	VP	Sell	1,447	$9.79	$14,166.13
4/17/2015	Ronald Steckel	VP	Sell	1,667	$9.86	$16,436.62
3/17/2015	Ronald Steckel	VP	Sell	11,358	$10.08	$114,488.64
3/10/2015	Ronald Steckel	VP	Sell	1,250	$10.03	$12,537.50
2/17/2015	Ronald Steckel	VP	Sell	1,650	$9.79	$16,153.50
1/20/2015	Ronald Steckel	VP	Sell	1,650	$9.03	$14,899.50
12/17/2014	Ronald Steckel	VP	Sell	1,650	$8.52	$14,058.00
11/17/2014	Ronald Steckel	VP	Sell	1,650	$8.28	$13,662.00
11/6/2014	William M Moore	Director	Buy	5,000	$7.79	$38,950.00
10/12/2014	Catalyst Fund Ix L.P Blueline	Director	Buy	17,237	$8.11	$139,792.07
10/10/2014	Catalyst Fund Ix L.P Blueline	Director	Buy	12,798	$8.02	$102,639.96
9/5/2014	Catalyst Fund Ix L.P Blueline	Director	Buy	8,432	$7.99	$67,371.68
8/29/2014	Catalyst Fund Ix L.P Blueline	Director	Buy	4,272	$7.92	$33,834.24
8/22/2014	James B Hawkins	Director	Sell	600	$8.03	$4,818.00
8/18/2014	Ronald Steckel	VP	Sell	1,650	$8.00	$13,200.00
8/15/2014	James B Hawkins	Director	Sell	14,400	$8.10	$116,640.00
8/14/2014	James B Hawkins	Director	Sell	2,714	$8.08	$21,929.12
8/13/2014	James B Hawkins	Director	Sell	9,786	$8.11	$79,364.46
8/11/2014	Garrett A Garrettson	Director	Sell	2,810	$8.30	$23,323.00
7/31/2014	Ronald Steckel	VP	Sell	761	$8.00	$6,088.00
7/21/2014	James H Mackaness	CFO	Sell	1,000	$7.62	$7,620.00
6/23/2014	James H Mackaness	CFO	Sell	2,000	$8.24	$16,480.00
6/17/2014	Ronald Steckel	VP	Sell	1,650	$8.20	$13,530.00
6/6/2014	Catalyst Fund Ix L.P Blueline	Director	Buy	7,390	$8.32	$61,484.80
6/3/2014	William M Moore	CEO	Buy	5,000	$8.48	$42,400.00
5/21/2014	James H Mackaness	CFO	Sell	3,000	$8.73	$26,190.00
5/19/2014	Ronald Steckel	VP	Sell	1,650	$8.82	$14,553.00
5/9/2014	William M Moore	CEO	Buy	5,000	$8.40	$42,000.00
4/22/2014	James H Mackaness	CFO	Sell	4,000	$8.74	$34,960.00
4/17/2014	Ronald Steckel	VP	Sell	1,650	$8.88	$14,652.00
3/21/2014	James H Mackaness	CFO	Sell	4,000	$9.03	$36,120.00
3/17/2014	Ronald Steckel	VP	Sell	1,650	$9.07	$14,965.50
2/18/2014	Ronald Steckel	VP	Sell	1,650	$8.60	$14,190.00
1/17/2014	Ronald Steckel	VP	Sell	1,650	$10.42	$17,193.00
12/17/2013	Ronald Steckel	VP	Sell	1,650	$8.56	$14,124.00
12/2/2013	James H Mackaness	CFO	Sell	10,000	$10.52	$105,200.00
9/6/2013	Ruediger Naumann-Etienne	Director	Buy	3,600	$5.99	$21,564.00
8/9/2013	William M Moore	CEO	Buy	10,000	$5.88	$58,800.00
6/19/2013	Eduardo Arias	VP	Sell	22,768	$5.43	$123,630.24
6/18/2013	James H Mackaness	CFO	Sell	19,862	$4.58	$90,967.96
6/17/2013	Eduardo Arias	VP	Sell	4,532	$5.39	$24,427.48
6/14/2013	James H Mackaness	CFO	Sell	10,568	$5.38	$56,855.84
6/13/2013	James H Mackaness	CFO	Sell	1,400	$5.30	$7,420.00
6/11/2013	Eduardo Arias	VP	Sell	1,000	$5.61	$5,610.00
6/11/2013	James H Mackaness	CFO	Sell	1,200	$5.61	$6,732.00
6/10/2013	Eduardo Arias	VP	Sell	2,400	$5.38	$12,912.00
6/10/2013	James H Mackaness	CFO	Sell	6,970	$5.36	$37,359.20
6/6/2013	William M Moore	CEO	Buy	2,000	$5.42	$10,840.00
5/17/2013	Eduardo Arias	VP	Sell	10,000	$6.30	$63,000.00
3/8/2013	Ruediger Naumann-Etienne	Director	Buy	2,400	$4.80	$11,520.00
3/7/2013	William M Moore	CEO	Buy	10,000	$4.66	$46,600.00
9/6/2012	William M Moore	CEO	Buy	10,000	$3.76	$37,600.00
8/15/2012	Catalyst Fund Ix L.P Blueline	Major Shareholder	Buy	60,900	$3.19	$194,271.00

(Data available from 1/1/2013 forward)

Latest Headlines for Iridex Corp. (NASDAQ:IRIX)

Date	Headline
	IRIDEX : Announces Long-Term Glaucoma Efficacy Data for Patients Treated with MicroPulse® P3 Probe Technology (NASDAQ:IRIX) www.4-traders.com - September 17 at 10:13 AM
	IRIDEX Announces Long-Term Glaucoma Efficacy Data for Patients Treated with MicroPulse® P3 Probe Technology (NASDAQ:IRIX) www.publicnow.com - September 7 at 9:06 AM
	ETF’s with exposure to IRIDEX Corp. : August 24, 2016 (NASDAQ:IRIX) www.capitalcube.com - August 24 at 5:34 PM
	Principal Accounting Officer of IRIDEX Corporation (NASDAQ:IRIX), Dizon Romeo R, sells 1,690 shares worth $22,817 (NASDAQ:IRIX) empowerednews.net - August 23 at 5:53 PM
	Edited Transcript of IRIX earnings conference call or presentation 4-Aug-16 9:00pm GMT (NASDAQ:IRIX) finance.yahoo.com - August 15 at 9:16 PM
	IRIDEX Corp. :IRIX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016 (NASDAQ:IRIX) www.capitalcube.com - August 15 at 3:49 PM
	Iridex Has Returned 51.7% Since SmarTrend Recommendation (IRIX) (NASDAQ:IRIX) www.mysmartrend.com - August 9 at 5:50 PM
	IRIDEX Corporation: IRIDEX Reports 2016 Second Quarter, Six-Month Results (NASDAQ:IRIX) www.twst.com - August 5 at 8:44 AM
	Iridex reports 2Q loss (NASDAQ:IRIX) sg.finance.yahoo.com - August 5 at 8:44 AM
	Q2 2016 IRIDEX Corp Earnings Release - After Market Close (NASDAQ:IRIX) biz.yahoo.com - August 4 at 8:44 AM
	IRIDEX Announces Second Quarter 2016 Conference Call and Release Date (NASDAQ:IRIX) www.publicnow.com - July 28 at 4:18 PM
	ETF’s with exposure to IRIDEX Corp. : July 21, 2016 (NASDAQ:IRIX) www.capitalcube.com - July 21 at 2:09 PM
	IRIDEX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agre (NASDAQ:IRIX) biz.yahoo.com - July 11 at 4:17 PM
	IRIDEX Announces Atabak Mokari Will Be Chief Financial Officer And VP Corporate Development (NASDAQ:IRIX) www.publicnow.com - July 11 at 7:03 AM
	IRIDEX CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:IRIX) biz.yahoo.com - June 21 at 4:17 PM
	IRIDEX to Present at the Singular Research 11th Annual Best of the Uncovereds Spring Select Conference (NASDAQ:IRIX) www.publicnow.com - June 2 at 4:35 PM
	Investors’ Pick for May 20 – PQ, AQMS, BRC, IRIX, USMD, DWSN, UNB (NASDAQ:IRIX) www.fxpips.com - May 20 at 11:43 AM
	IRIDEX Corp. :IRIX-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:IRIX) www.capitalcube.com - May 11 at 11:57 AM
	IRIDEX Announces Cyclo G6™ with MicroPulse® P3 Clinical Data Presented at ARVO and ASCRS Annual Meetings (NASDAQ:IRIX) www.publicnow.com - May 10 at 7:18 AM
	Iridex posts 1Q profit (NASDAQ:IRIX) sg.finance.yahoo.com - May 5 at 6:24 PM
	IRIDEX Reports 2016 First Quarter Results (NASDAQ:IRIX) finance.yahoo.com - May 5 at 4:05 PM
	Q1 2016 IRIDEX Corp Earnings Release - After Market Close (NASDAQ:IRIX) biz.yahoo.com - May 5 at 7:07 AM
	IRIDEX Announces First Quarter 2016 Conference Call and Release Date (NASDAQ:IRIX) www.publicnow.com - April 28 at 4:36 PM
	IRIDEX CORP Files SEC form 10-K, Annual Report (NASDAQ:IRIX) biz.yahoo.com - March 31 at 5:20 PM
	IRIDEX Gains Patent Approvals Covering TxCell™-Guided MicroPulse® Laser Therapy; Predictably Enables Faster, Durable Treatments for Glaucoma and Retinal Diseases (NASDAQ:IRIX) www.publicnow.com - March 22 at 4:31 PM
	4:07 pm IRIDEX gains 2 patent approvals covering TXcell-guided micropulse laser therapy, enables treatments for glaucoma and retinal diseases (NASDAQ:IRIX) finance.yahoo.com - March 22 at 4:07 PM
	ETF’s with exposure to IRIDEX Corp. : March 10, 2016 (NASDAQ:IRIX) www.capitalcube.com - March 10 at 1:54 PM
	IRIDEX Corp. :IRIX-US: Earnings Analysis: 2015 By the Numbers (NASDAQ:IRIX) www.capitalcube.com - March 9 at 12:03 PM
	IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:IRIX) biz.yahoo.com - March 7 at 5:17 PM
	Edited Transcript of IRIX earnings conference call or presentation 3-Mar-16 10:00pm GMT (NASDAQ:IRIX) finance.yahoo.com - March 4 at 2:47 PM
	Iridex posts 4Q profit (NASDAQ:IRIX) sg.finance.yahoo.com - March 3 at 5:20 PM
	IRIDEX Corp Earnings Call scheduled for 5:00 pm ET today (NASDAQ:IRIX) biz.yahoo.com - March 3 at 5:00 PM
	IRIDEX Reports 2015 Fourth Quarter, Full Year Results (NASDAQ:IRIX) finance.yahoo.com - March 3 at 4:05 PM
	Q4 2015 IRIDEX Corp Earnings Release - After Market Close (NASDAQ:IRIX) biz.yahoo.com - March 3 at 7:07 AM
	IRIDEX Receives CE Mark for Cyclo G6™ Laser System for the Treatment of Multiple Stages of Glaucoma (NASDAQ:IRIX) finance.yahoo.com - February 16 at 6:30 AM
	Coverage initiated on IRIDEX by Singular Research (NASDAQ:IRIX) finance.yahoo.com - January 26 at 2:15 PM
	IRIDEX CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:IRIX) biz.yahoo.com - January 12 at 4:04 PM
	IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:IRIX) biz.yahoo.com - January 11 at 4:04 PM
	IRIDEX Announces Preliminary Unaudited Revenues for 2015 Fourth Quarter and Full Year (NASDAQ:IRIX) www.noodls.com - January 11 at 6:47 AM
	Edited Transcript of IRIX earnings conference call or presentation 5-Nov-15 10:00pm GMT (NASDAQ:IRIX) finance.yahoo.com - January 8 at 12:00 PM
	IRIDEX Corp. Earnings Analysis: Q3, 2015 By the Numbers (NASDAQ:IRIX) www.capitalcube.com - December 21 at 12:24 PM
	IRIDEX CORP Financials (NASDAQ:IRIX) finance.yahoo.com - December 8 at 1:17 PM
	Technical Movement Driving Equities - Research on BIND Therapeutics, Edgewater Technology, IRIDEX, and PRGX Global (NASDAQ:IRIX) finance.yahoo.com - December 2 at 8:30 AM
	Do Hedge Funds Love IRIDEX Corporation (IRIX)? (NASDAQ:IRIX) www.insidermonkey.com - December 1 at 5:29 PM
	IRIDEX to Showcase Cyclo G6™ Laser System Equipped with MicroPulse® Tissue Sparing Glaucoma Technology at American Academy of Ophthalmology (AAO) Meeting (NASDAQ:IRIX) www.noodls.com - November 11 at 6:56 AM
	IRIDEX CORP Files SEC form 10-Q, Quarterly Report (NASDAQ:IRIX) biz.yahoo.com - November 10 at 5:05 PM
	Iridex posts 3Q profit (NASDAQ:IRIX) sg.finance.yahoo.com - November 5 at 6:48 PM